Predicting doses to organs-at-risk in prostate cancer intensity modulated radiotherapy

被引：0
|
作者：
Mallick, I. [1 ]
Saha, S. [1 ]
Arunsingh, M. [1 ]
Sarkar, A. [2 ]
Adhya, D. Guha [3 ]
Achari, R. [1 ]
机构：
[1] Tata Med Ctr, Dept Radiat Oncol, Kolkata, India
[2] Indian Inst Technol, Dept Mech Engn, Varanasi, Uttar Pradesh, India
[3] Indian Inst Technol, Sch Med Sci & Technol, Kharagpur, W Bengal, India
来源：
RADIOTHERAPY AND ONCOLOGY | 2020年 / 152卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PO-1575
引用
收藏
页码：S854 / S854
页数：1
相关论文
共 50 条
  • [1] A method to dynamically balance intensity modulated radiotherapy dose between organs-at-risk
    Das, Shiva K.
    MEDICAL PHYSICS, 2009, 36 (05) : 1744 - 1752
  • [2] Is there a role for radiation therapists in the delineation of organs-at-risk in conformal radiotherapy for prostate cancer?
    Fitzpatrick, K
    Kelly, C
    Thirion, P
    RADIOTHERAPY AND ONCOLOGY, 2005, 76 : S99 - S100
  • [3] Conformal radiotherapy of prostate cancer: What is the proper technique for sparing organs-at-risk?
    Peppa, V.
    Mazonakis, M.
    Kachris, S.
    Varveris, C.
    Damilakis, J.
    ONCOLOGY REPORTS, 2010, 23 (06) : 1663 - 1668
  • [4] DOES PLANNED-DOSE TO ORGANS-AT-RISK REFLECT DELIVERED-DOSE IN HEAD & NECK INTENSITY MODULATED RADIOTHERAPY?
    Puxeu Vaque, J.
    Correa, P.
    Shenoy, A.
    Husband, D.
    Mayles, H.
    RADIOTHERAPY AND ONCOLOGY, 2011, 99 : S462 - S462
  • [5] Intensity-modulated radiotherapy for prostate cancer
    Fischer-Valuck, Ben W.
    Rao, Yuan James
    Michalski, Jeff M.
    TRANSLATIONAL ANDROLOGY AND UROLOGY, 2018, 7 (03) : 297 - 307
  • [6] Beam path toxicity in candidate organs-at-risk: Assessment of radiation emetogenesis for patients receiving head and neck intensity modulated radiotherapy
    Kocak-Uzel, Esengul
    Gunn, G. Brandon
    Colen, Rivka R.
    Kantor, Micheal E.
    Mohamed, Abdallah S. R.
    Schoultz-Henley, Sara
    Mavroidis, Paniyotis
    Frank, Steven J.
    Garden, Adam S.
    Beadle, Beth M.
    Morrison, William H.
    Phan, Jack
    Rosenthal, David I.
    Fuller, Clifton D.
    RADIOTHERAPY AND ONCOLOGY, 2014, 111 (02) : 281 - 288
  • [7] Intensity modulated radiotherapy (IMRT) for prostate cancer: an update
    Fuks, Z.
    EJC SUPPLEMENTS, 2005, 3 (02): : 32 - 32
  • [8] A prospective study on radiation doses to organs at risk (OARs) during intensity-modulated radiotherapy for nasopharyngeal carcinoma patients
    Yao, Ji-Jin
    Chen, Fo-Ping
    Zhou, Guan-Qun
    Zhang, Wang-Jian
    Xu, Lin
    Wang, Xiao-Ju
    Lin, Li
    Ma, Jun
    Sun, Ying
    ONCOTARGET, 2016, 7 (16) : 21742 - 21752
  • [9] Persistently better treatment planning results of intensity-modulated (IMRT) over conformal radiotherapy (3D-CRT) in prostate cancer patients with significant variation of clinical target volume and/or organs-at-risk
    Fenoglietto, Pascal
    Laliberte, Benoit
    Allaw, Ali
    Ailleres, Norbert
    Idri, Katia
    Hay, Meng Huor
    Moscardo, Carmen Llacer
    Gourgou, Sophie
    Dubois, Jean-Bernard
    Azria, David
    RADIOTHERAPY AND ONCOLOGY, 2008, 88 (01) : 77 - 87
  • [10] Expanding Utilization of Intensity-Modulated Radiotherapy for Prostate Cancer
    Cooperberg, Matthew R.
    JAMA INTERNAL MEDICINE, 2013, 173 (12) : 1143 - 1144
12345